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mine structure-function correlations among presently available
compounds. Our initial findings are reported here, together
with a summary of unpublished observations in plant tissues.
MATERIALS AND METhODS
Materials.All derivativesof DPP werepreparedas describedprevi
ously (1). GTP, vinblastine, colchicine, and MES were obtained from
Sigma podophyllotoxin was from Aldrich; (8-'4CJGTP was from Mo
ravek Biochemicals and (3HJcolchicineand (3HJvinblastinewere from
Amersham. Maytansine was provided by the Natural Products Branch,
National Cancer Institute, and [3Hjmaytansinewas a generous gift of
Dr. D. G. Johns (9). GTP and [8-'4CJGTPwere repurifiedby ion
exchange gradient chromatography. Electrophoretically homogeneous
calf brain tubulin and MAPs purified by DEAE-cellulose chromatog
raphy were preparedas described previously (10). All drugs were
dissolved in dimethyl sulfoxide, and control reaction mixtures always
contained an equivalent amount of the solvent.
Methods. Measurement ofGTP hydrolysisand colchicine binding to
tubulin, turbidimetric analysis of microtubule assembly, and electron
microscopy of negatively stained specimens were performed as de
scribed elsewhere (10, 11). Measurement of the binding of radiolabeled
vinblastineandmaytansineto tubulinwasperformedbythecentrifugal
gel filtrationmethodof Penefsky(12) as describedin detailpreviously
(13). Analysis of drug effects on the mitotic index and on cytotoxicity
in cell culturewas performedwith murine L1210 leukemiacells, as
described by Wolpert-DeFilippes et a!. (14).
RESULTS
The basic structure of the DPP derivatives described here is
presented in Fig. 1, with structural details presented in Table
1. A variety of substituents at position 2 of the pyridazinone
ring and on the two phenyl rings have been observed in active
compounds (in all cases the substituents on the phenyl rings
have been identical). Virtually all active agents in both plant
and mammalian systems have had a nitrile group at position 4.
Summary of Findings in Plant Tissues. The observation of
significant herbicidal activity in the DPP derivative NSC
362448 led to efforts to define its mechanism ofaction. Studies
with root tip tissue demonstrated defective cell division, with
coalescence of condensed chromosomes in the cell center, and
the disappearance of microtubules. Unusual new structures
were also observed: macrotubules about 75 nm in diameter, 3
times as wide as normal microtubules. A large number of DPP
derivatives were also observed to inhibit flagellar regrowth in
Chiamydomonascells (cf Refs. 15 and 16). In this study the
primary comparison was between a group of derivatives with
varied substituents at position 2 of the pyridazinone ring, a
nitrile group at position 4, and unsubstituted phenyl rings.
Although some of the compounds inhibited flagellar regrowth
by 50% at drug doses as low as 0.4 gsM,none of the agents most
active in inhibiting flagellar regrowth were among the drugs
most active in inhibiting bovine tubulin polymerization in vitro.
Demonstration That Tubulin Is the Probable Target of DPP
Derivatives in Mammalian Tissues. A group of the DPP deny
atives was submitted to the National Cancer Institute for screen
ABSTRACT
A series of derivatives of 5,6-diphenylpyridazin-3-one (DPP) was
examined for interactions with calf brain tubulin followingthe demon
stration that many members ofthe class caused significant mitotic effects
inintactanimals,whileothershadactivityagainstmarineP388leukemia.
In L1210cells severalDPP derivativescauseda rise in the mitoticindex
which correlated well with the cytotoxicity of the drugs. Active DPP
derivatives markedly stimulated tubulin-dependent guanosine triphos
phatehydrolysisandinhibitedtubulinpolymerizationor inducedtubulin
oligomerformation,dependingonspecificreactionconditions.Thesenew
agents, however,did not interfere with the bindingto tubulin of radiola
beled colchicine, vinblastine, maytansine, or guanosine triphosphate.
They thus appearto bindat a previouslyUndescribedsite on the tubulin
molecule. Some DPP derivativeshave significantherbicidalactivity,
causing mitotic disruption and a rise in the mitotic index in seedlingroot
tissues. Although the DPP derivatives most toxic to plant tissues differ
fromthose most active in inhibitingcalf braintubulinpolymerization,
virtually all active compoundsbear a nitrile substituent at position 4 of
the pyridazinonering. Most activederivativesalso bearsubstituentsof
varying structure at position 2 ofthis ring, but no clear structure-function
pattern is apparent at this position. The phenyl rings in the most active
herbicidal DPP derivatives either are unsubstituted or bear fluorine
atoms. Derivativeswith chlorinesubstituentshave no detectableherbi
cidal activity. In contrast, interactions with calf brain tubulin are sub
stantiallyenhancedif the phenylringsbearchlorinesubstituents.
INTRODUCTION
The observation of antihypertensive activity for a DPP2 de
rivative led to the synthesis of several analogues to explore
structure-activity relationships in this novel class of compounds
(1, 2) (see Fig. 1 and Table 1). Although several of these agents
were active in reducing blood pressure in a spontaneously
hypertensive rat model (1, 2), some DPP derivatives displayed
significant herbicidai activity (3). Preliminary toxicological
studies of the herbicidal compounds included the observation
of bizarre mitotic figures in renal tissue (4, 5). A number of the
agents were therefore submitted to the National Cancer Insti
tute for screening for antineoplastic activity, and a significant
increase in survival of mice given simultaneous injections of
P388 leukemia cells and selected DPP derivatives was observed.
Since we have been screening antineoplastic drugs of uncertain
mechanism ofaction for their effects on tubulin-dependent GTP
hydrolysis (6â€”8)to identify new antimitotic agents, we exam
med these compounds. They were found to stimulate GTP
hydrolysis dramatically, and as a consequence we have exam
med in detail the interactions ofthis class ofdrugs with tubulin.
In particular, we wanted to establish that they were antimitotic
agents in mammalian cells, determine their effects on tubulin
polymerization, locate their binding site on tubulin, and deter
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Table 2 Stimulation oftubulin-dependent GTP hydrolysis by DPP derivatives
Each 50-jd reaction mixture contained tubulin (1 mg/mI), 0.1 mr@i(8-â€•C@GTP,
the indicated drug at 0.1 mr@i,1%dimethyl sulfoxide (v/v), 0.1 M MES (pH 6.4),
and 0.5 mM MgCI2. Incubation was for 20 mm at 37'C. Data are expressed as
nmol of (8-'4CJGDP formed per ml of reaction. This experiment was performed
twice with comparable results. In addition, stimulation of GTP hydrolysis by
DPP derivatives was observed in six experiments in 1 M glutamate and in two
experiments with heat-treated MAPs (cf Ref.8).Drug
added nmol GDPformedNone
1.7
Colchicine 8.9
NSC 362453 44.8
5,6-DIPHENYLPYRIDAZIN-3-ONE DERIVATIVES
Fig. I . Structural formula of the DPP derivatives.
Table I Inhibition ofmicrotubule assembly by DPP derivatives
ID,@ values were established in 0.25-ml reaction mixtures containing tubulin
(1.0 mg/mI), MAPS purified by DEAE-cellulose chromatography (0.5 mg/mI)
(10), 0.1 M MES (pH 6.9), 0.5 mM MgCl2, 1.0 mr@iGTP, 2% (v/v) dimethyl
sulfoxide, and varying concentrations of the indicated drugs. ID,o values were
basedon a minimum of two independentdeterminations.
Drug (NSC no.) Xe Rb
362458
362460
601680
601683
602747
603334
a ID,@,, concentration of drug resulting in a 50% reduction in the turbidity
reading after a 20-mm incubation at 37T.
a i@ocationsof X and R in the DPP derivatives is as indicated in Fig. 1.
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Fig. 2. Cytotoxic and antimitotic effects of DPP derivatives on murine L1210
leukemia cells. These studies were performed as described by Wolpert-DeFilippes
etal. (14). Dimethyl sulfoxideconcentrationwas 1%(v/v). 0, 0, @,mitotic index
(control, 2.8% mitoses); â€¢,U, A, cytotoxic effects of the drugs (control, 3.9 x
10' cells/mI). Details of drug structures are presented in Table 1. NSC 362453
(0, â€¢);NSC 351478 (Lx,A); NSC 602746 (0, U). This study was performed in
its entirety a single time. Similar results were obtained with NSC 362453 in a
second experiment. In addition, a high mitotic index was obtained two additional
times in a cell culture treated with 100 @MNSC 351478.
Fig. 3. Inhibition of microtubule assembly by NSC 362449. Each 0.25-mi
reaction mixture contained tubulin (0.75 mg/mI), MAPs purified by DEAE
cellulose chromatography (0.38 mg/mI), 1.0 mi.i GTP, 0.1 M MES (pH 6.9), 0.5
mM MgCl2, 2% (v/v)dimethyl sulfoxide, and NSC 362449 (see Table 1 for details
of drug structure) at the following concentrations: Curve 1, none; curve 2, 5 @;
Curve3, 7.5 aiM;Curve4, 10 @LM.At zero time the electronic temperaturecontroller
(see Ref. 10) was set at 37'C; at the time indicated by the arrow on the abscissa,
the temperature controller was set at 0C. Similar results were obtained in at least
four experiments.
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MINUTES
ing for antineoplastic activity. Several compounds proved active
against murine P388 leukemia, but these differed from the most
. active herbicides. (The most promising drugs at this point
appear to be NSC 351478 and NSC 362454.) Nevertheless,
since tubulin appeared to be a likely target for this class of
agents, we examined the effect of DPP derivatives on tubulin
dependent GTP hydrolysis (6â€”8).Many of these drugs stimu
lated the reaction under three different conditions (in 1 M
glutamate and in 0. 1 M MES both with and without heat
treated MAPs). Table 2 compares the potent stimulation of
GTP hydrolysis by NSC 362453 in 0.1 M MES without MAPs
to the much less marked effect of colchicine, the first drug
reported to stimulate tubulin-dependent GTP hydrolysis (17).
The GTPase studies and the observations in plant tissues
predict that the DPP derivatives should cause mitotic arrest in
mammalian cells in culture. This was confirmed with three
drugs studied in murine L1210 leukemia cells (Fig. 2). The rise
in mitotic index correlated well with cytotoxic effects of the 3
compounds.
DPP Derivatives Inhibit Microtubule Assembly and/or Induce
Tubulin Oligomer Formation. Generally antimitotic agents in
hibit microtubule assembly in vitro. This was readily demon
strated with many DPP derivatives (Fig. 3; also see Table 1).
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Fig. 4. Morphology of tubulin oligomers
induced with NSC 362453 (see Table 1 for
details of drug structure) and vinblastine. A
and B, oligomers formed with NSC 362453.
The 0.25-mi reaction mixture contained tubu
un (1.0 mg/mI), 0.1 mM GTP, 1.0 M mono
sodium glutamate (pH 6.6), 1.0 mM MgCI2,
4% (v/v) dimethyl sulfoxide, and 0.1 mM NSC
362453. After 20 mm at 37'C, a negatively
stained specimen was prepared and examined
in the electron microscope. C, oligomers
formed with vinbIastine. Reaction mixture as
above,exceptthat the drugwas 10pMvinbias
tine instead of NSC 362453. A, x 7,900 Band
C, x 52,700.
4 44
One of the most inhibitory members of this class of drugs was
NSC 362449. In a system consisting of purified tubulin and
MAPs (Fig. 3), progressive inhibition ofnucleation, elongation,
and extent of polymerization was observed as the drug concen
tration was raised, with complete inhibition occurring at 10 tiM.
In a second series of experiments we demonstrated that glyc
erol-induced polymerization of purified tubulin (18) was inhib
ited by NSC 362449 (data not presented), confirming that the
target of the DPP derivatives is tubulin and not the MAPs (as
predicted by the GTPase experiments without MAPs).
In 1.0 Mglutamate several of the DPP derivatives were found
to induce cold-irreversible turbidity development rather than
simply inhibit cold-reversible polymerization, as is the case with
most other antimitotic drugs (6â€”8).Electron microscopic ex
amination of reaction mixtures at 37Â°Cdemonstrated the for
mation ofwell-defined helical oligomers. Fig. 4A presents a low
magnification (x7,900) view of these structures; Fig. 4B shows
a high magnification (x52,700) view. There is a clearly visible
filamentous substructure, perhaps representing protofilaments
(2 and occasionally 3 filaments can be distinguished). The
helical oligomers are relatively short, and the repeat distance
in the helix is about 90 nm. Neither turbidity development nor
oligomer formation required GTP, and GTP had little effect
on this reaction; nor is there turbidity development or oligomer
formation at low ionic strength without MAPs. With some
preparations of MAPs, DPP derivative-induced turbidity de
velopment also occurs, but the structures formed are not as
ordered as those in glutamate. We have not yet been able to
correlate DPP derivative-induced turbidity development with a
specific MAP component (cf Ref. 19).
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Table 3 Failure ofDPP derivatives to inhibit the binding of radiolabeled
drugsto tubulin
% of control after following
radiolabeled drug added
equivalent to a bromine at that position and that a compound
with a chlorine substituent at position 4' is about 3â€”4times
more active than one with a chlorine at position 2', which is in
turn 2â€”3 times more inhibitory than an unsubstituted corn
pound.
Finally, Fig. 5 presents the structures of three inactive corn
pounds. The two phenyl rings seem to be essential for inhibition
of microtubule assembly, and they must have at least some
degree of mobility (alternatively, the fused structure presented
in Fig. 5 may represent an unfavorable conformation for an
interaction with tubulin). All compounds with no substituent
or a large substituent at position 4 of the pynidazinone ring
have been inactive.
DISCUSSION
The DPP derivatives are a new rnultiagent class of antimitotic
drugs, many ofwhich interact directly with bovine brain tubulin.
Although no direct interaction with plant tubulin has been
documented, it is likely that their effects in inhibiting flagellar
regrowth and inducing mitotic disruption derive from an anal
ogous interaction with plant tubulin. It must be emphasized
that specific DPP derivatives have maximum inhibitory activity
only with one class of organisms. Those most active in plant
tissues interact only weakly with bovine tubulin and vice versa.
In structure-function studies on herbicidal activity, compounds
with unsubstituted phenyl rings were highly active, as were
those with fluorine substituents. Chlorine groups on the two
phenyl rings eliminated herbicidal activity.3 The opposite is the
case for interactions of DPP derivatives with bovine tubulin.
The interactions of the DPP derivatives with tubulin are
reminiscent of colchicine and many colchicine analogues in
stimulating tubulin-dependent GTP hydrolysis even as they
inhibit the microtubule assembly reaction associated with GTP
breakdown (6â€”8,17). However, these drugs do not inhibit the
binding of colchicine to tubulin.
The DPP derivatives are also reminiscent of the Vinca alka
bids in that they inhibit microtubule assembly and induce
tubulin oligomer formation. In addition, distinct new structures
(macrotubules) were observed in DPP derivative-treated seed
ling roots. Although it is not yet known whether these macro
tubules contain tubulin, they may bear some relationship to the
oligomeric structures formed from purified bovine tubulin in
glutamate. Perhaps analogously, the tight spirals induced by
Vinca alkaloids in vitro (19, 20) differ greatly morphologically
from the tubulin paracrystals observed in cells treated with
Vincaalkaloids.Nevertheless,the DPP derivative-inducedoil
gomer differs morphologically from the Vinca alkaloid-induced
oligomer, and DPP derivatives are unable to inhibit the binding
of either vinbiastine or maytansine to tubulin (9). Moreover,
both vinblastine and maytansine inhibit rather than stimulate
tubulin-dependent GTP hydrolysis (7, 8, 17).
The DPP derivatives thus seem to bind to a previously
undescribed site on tubulin, for they also do not inhibit the
binding of guanine nucleotides at the exchangeable GTP site.
Definitive proofofthis hypothesis requires radiolabeled agents,
and we are attempting their synthesis.
Some ofthe DPP derivatives (particularly NSC 351478) were
effective in the treatment of P388 leukemia in mice. The
structure-activity studies suggest promising leads for the syn
thesis of additional compounds. While the substituents at po
sition 2 of the pyridazinone ring do not fall into a clear pattern,
3 L. J. Powers, unpublished data.
a Each 0.1-mi reaction mixture contained tubuiin (0.1 mg/mI), 5 pM (3HJ
colchicine, the competing drug at 0.5 m@.i,and 5% (v/v) dimethyl sulfoxide.
Further reaction components and further experimental details are as described
previously (10). Comparable results were obtained in three different experiments.
a Each 0.4-mi reaction mixture contained tubulin (1.0 mg/mi), 0.1 M MES
(pH 6.9), 0.5 mM MgC12,0.1 mr.iGTP, 2.5% (v/v) dimethyl sulfoxide, and either
25 pM (3Hlvinbiastine with the competing drugsat I mM or 10 pM (3Hjmaytansine
with the competing drugs at 0.25 mM. Incubation was at room temperature for
20 mm. Comparable results were obtained in three different experiments with
vinblastine. The maytansine experiment was performed once.
cH3-tk@,.AO @)H2 CH2OH
@ CH2 OH
c@.N
CH2OH
Fig. 5. Formulas of compounds which are structurally related to the DPP
derivatives and which do not inhibit in vitro microtubule assembly.
The Vinca alkaloids have long been known to induce forma
tion of aberrant tubulin structures iii vitro and in vivo, including
formation of oligomers of purified tubulin in 1.0 M glutamate.
To determine whether there was any relationship between the
DPP-induced oligomers and those formed with vinblastine, we
examined the morphology of the vinblastine-induced structures
(Fig. 4C). Although these were also helical, they were coiled
much more tightly and appeared to be considerably larger than
those formed with the DPP derivatives. The vinblastine-induced
structures formed in 1.0 M glutamate are morphologically sim
ilar to those described by other workers (19, 20) using different
reaction conditions.
Effects of DPP Derivatives on Drug and Nucleotide Binding
to Tubulin. To determine whether the DPP derivatives bound
at a previously described site on tubulin, we examined the effect
of these drugs on the binding of radiolabeled colchicine, yin
blastine, and maytansine (Table 3). No inhibitory effect was
observed. These new agents also do not affect the binding of
GTP to tubulin (data not presented), as predicted by their brisk
stimulation of GTP hydrolysis requiring turnover of GTP at
the exchangeable site.
Structure-Activity Relationships. The availability of a large
number of DPP derivatives permitted a relatively extensive
analysis of the structural requirements for interaction of this
class of drug with tubulin in vitro. Our most important findings
are summarized in Table 1, in which the drug concentration
required to inhibit the extent of microtubule assembly by 50%
after 20 minutes at 37Â°Cwas determined. The drug concentra
tions required to inhibit reaction rate by 50% were considerably
lower, but relative activities of the drugs were unaltered.
No clear pattern ofactivity related to substituents at position
2 of the pynidazinone ring emerged from these experiments. In
fact, two ofthe most active inhibitors ofassembly(NSC 351477
and NSC 602746) were unsubstituted at this position. A clear
pattern is observed, however, when the symmetrical substituents
on the phenyl rings are considered. Activity is progressively
enhanced with a fluorine atom at position 4', a bromine at 4',
a chlorine at 4', and two chlonines at 3' and 4'. Available
compounds also indicate that a methyl group at position 4' is
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alterations at this position can have major effects on the activity
of the resulting compounds. More specific was the effect of
chlorinating the phenyl rings. Position 4' seems most impor
tant, but a second chlorine at position 3' further enhanced in
vitro inhibition of microtubule assembly.
Position 4 of the pyridazinone ring is also of major impor
tance. Virtually all compounds which inhibit polymerization of
bovine tubulin or which have herbicidal activity bear a nitrile
group at this position. A large number of inactive compounds
have been examined bearing a variety of substituents (or none
at all; see Fig. 5). A single compound of this group (analogous
to NSC 362449, but bearing a chlorine instead of a nitrile at
position 4) has had activity. This compound was about one
third as effective as NSC 362449 in inhibiting microtubule
assembly. Thus, while the nitrile group cannot be considered
essential for inhibitory activity in the DPP derivative series, it
is nonetheless ofmajor importance. It appears that a substituent
is required at position 4 and that it must be relatively small.
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